Bon Koo
Associate Professor
MANAGEMENT SCIENCES
University of Waterloo
Canada
Biography
Bon Koo is an Associate Professor, and Associate Chair for Graduate Studies and Research in the Management Sciences department at the University of Waterloo. His principal areas of research include the economics of R&D and intellectual property rights, management of technology, science and technology policy, and the economics of biotechnology. Dr. Koo is affiliated with the International Science & Technology Practice & Policy (InSTePP) at the University of Minnesota, and Canadian Agricultural Innovation and Regulation Network (CAIRN). He has published several reports, journals, and articles on topics such as intellectual property rights policies, technology standards, conservation of genetic resources, and biotechnology and agricultural innovation.
Research Interest
Technology Management And Innovation Economics Of Intellectual Property Rights Licensing And Contracts In Technology
Publications
-
Koo BK, Erglis A, Doh JH, Daniels DV, Jegere S, Kim HS, Dunning A, DeFrance T, Lansky A, Leipsic J, Min JK. Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms: results from the prospective multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve) study. Journal of the American College of Cardiology. 2011 Nov 1;58(19):1989-97.
-
de Lau W, Barker N, Low TY, Koo BK, Li VS, Teunissen H, Kujala P, Haegebarth A, Peters PJ, van de Wetering M, Stange DE. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature. 2011 Aug 18;476(7360):293.
-
Kang HJ, Kim HS, Zhang SY, Park KW, Cho HJ, Koo BK, Kim YJ, Lee DS, Sohn DW, Han KS, Oh BH. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. The Lancet. 2004 Mar 6;363(9411):751-6.
